252 related articles for article (PubMed ID: 28901470)
41. Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3.
Garg G; Gibbs J; Belt B; Powell MA; Mutch DG; Goedegebuure P; Collins L; Piwnica-Worms D; Hawkins WG; Spitzer D
BMC Cancer; 2014 Jan; 14():35. PubMed ID: 24447304
[TBL] [Abstract][Full Text] [Related]
42. Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells.
Chang CC; Hsu WH; Wang CC; Chou CH; Kuo MY; Lin BR; Chen ST; Tai SK; Kuo ML; Yang MH
Cancer Res; 2013 Jul; 73(13):4147-57. PubMed ID: 23687336
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of mesothelin as a novel strategy for targeting cancer cells.
Wang K; Bodempudi V; Liu Z; Borrego-Diaz E; Yamoutpoor F; Meyer A; Woo RA; Pan W; Dudek AZ; Olyaee MS; Esfandyari T; Farassati F
PLoS One; 2012; 7(4):e33214. PubMed ID: 22485139
[TBL] [Abstract][Full Text] [Related]
44. Flagellin-induced tolerance of the Toll-like receptor 5 signaling pathway in polarized intestinal epithelial cells.
Sun J; Fegan PE; Desai AS; Madara JL; Hobert ME
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G767-78. PubMed ID: 17138965
[TBL] [Abstract][Full Text] [Related]
45. Pseudomonas aeruginosa stimulates tyrosine phosphorylation of and TLR5 association with the MUC1 cytoplasmic tail through EGFR activation.
Kato K; Lillehoj EP; Kim KC
Inflamm Res; 2016 Mar; 65(3):225-33. PubMed ID: 26645913
[TBL] [Abstract][Full Text] [Related]
46. Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells.
Tallant T; Deb A; Kar N; Lupica J; de Veer MJ; DiDonato JA
BMC Microbiol; 2004 Aug; 4():33. PubMed ID: 15324458
[TBL] [Abstract][Full Text] [Related]
47. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
[TBL] [Abstract][Full Text] [Related]
48. Molecular Imaging of Mesothelin-Expressing Ovarian Cancer with a Human and Mouse Cross-Reactive Nanobody.
Prantner AM; Yin C; Kamat K; Sharma K; Lowenthal AC; Madrid PB; Scholler N
Mol Pharm; 2018 Apr; 15(4):1403-1411. PubMed ID: 29462558
[TBL] [Abstract][Full Text] [Related]
49. Phosphorylation of the proline-rich domain of WAVE3 drives its oncogenic activity in breast cancer.
Kansakar U; Wang W; Markovic V; Sossey-Alaoui K
Sci Rep; 2021 Feb; 11(1):3868. PubMed ID: 33594155
[TBL] [Abstract][Full Text] [Related]
50. Src kinases central to T-cell receptor signaling regulate TLR-activated innate immune responses from human T cells.
Sharma N; Akhade AS; Qadri A
Innate Immun; 2016 Apr; 22(3):238-44. PubMed ID: 26888964
[TBL] [Abstract][Full Text] [Related]
51. OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion.
Dai X; Ge J; Wang X; Qian X; Zhang C; Li X
Oncol Rep; 2013 Jan; 29(1):155-60. PubMed ID: 23076549
[TBL] [Abstract][Full Text] [Related]
52. The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion.
Sossey-Alaoui K; Bialkowska K; Plow EF
J Biol Chem; 2009 Nov; 284(48):33019-29. PubMed ID: 19801681
[TBL] [Abstract][Full Text] [Related]
53. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
Nakamura K; Terai Y; Tanabe A; Ono YJ; Hayashi M; Maeda K; Fujiwara S; Ashihara K; Nakamura M; Tanaka Y; Tanaka T; Tsunetoh S; Sasaki H; Ohmichi M
Oncol Rep; 2017 Jun; 37(6):3189-3200. PubMed ID: 28440503
[TBL] [Abstract][Full Text] [Related]
54. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
Kenda Suster N; Smrkolj S; Virant-Klun I
J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
[TBL] [Abstract][Full Text] [Related]
55. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.
Ha JH; Ward JD; Radhakrishnan R; Jayaraman M; Song YS; Dhanasekaran DN
Oncotarget; 2016 Jun; 7(25):37664-37679. PubMed ID: 27166196
[TBL] [Abstract][Full Text] [Related]
56. Ectopic repression of receptor tyrosine kinase-like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial-mesenchymal transition.
Xu Y; Ma YH; Pang YX; Zhao Z; Lu JJ; Mao HL; Liu PS
Tumour Biol; 2017 May; 39(5):1010428317701627. PubMed ID: 28475014
[TBL] [Abstract][Full Text] [Related]
57. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
58. Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer.
Rhee SH; Im E; Pothoulakis C
Gastroenterology; 2008 Aug; 135(2):518-28. PubMed ID: 18538140
[TBL] [Abstract][Full Text] [Related]
59. Sex-determining region Y-box protein 3 induces epithelial-mesenchymal transition in osteosarcoma cells via transcriptional activation of Snail1.
Qiu M; Chen D; Shen C; Shen J; Zhao H; He Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):46. PubMed ID: 28335789
[TBL] [Abstract][Full Text] [Related]
60. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
